The public can comment on the FDA’s committee meeting tomorrow (February 26th) to discuss the Emergency use Authorization for the Johnson & Johnson / Janssen vaccine candidate. Members of the public can submit comments via an online system here or via the mail. Attached is my letter. The main theme is transparency. The online system submission form sets a limit of 5,000 characters but this ended up being around 6,500 so it was submitted as an attachment.